BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:32 PM
 | 
Apr 27, 2009
 |  BC Extra  |  Company News

EC approves Conbriza

The EC approved Conbriza bazedoxifene from Wyeth (NYSE:WYE) to treat postmenopausal osteoporosis in women at...

Read the full 62 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >